His parents have now filed a lawsuit against both the pharmacy benefits-management company and Walgreens, claiming they are responsible for their son's death. The Schmidtknechts' ...

The family of Cole Schmidtknecht accuse OptumRx and Walgreens of having a part in their son’s death. As we reported last month, the 22-year-old didn’t have an asthma inhaler when he suffered a ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The “Big Three” PBMs are kicking their suit up to the 8th Circuit and, in the meantime, are once again asking a Missouri ...

In the lawsuit complaint, Cole's parents, Bil and Shanon Schmidtknecht, allege both OptumRx and Walgreens were negligent and bear responsibility for their son's death. Five days before Cole's ...

Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventative asthma inhalers in January 2024 when he went to his Walgreens pharmacy in Appleton, Wisconsin. The pharmacy ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

The Schmidtknechts allege that pharmacy benefits management company OptumRX violated Wisconsin law by raising the cost of the medication without a valid medical reason and failing to provide 30 ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

The family of Cole Schmidtknecht accuse OptumRx and Walgreens of having a part in their son’s death. As we reported last month, the 22-year-old didn’t have an asthma inhaler when he suffered a ...